Talis Biomedical Corporation Retained Earnings
Talis Biomedical Corporation had Retained Earnings of -$561.85 million as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-08-19
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$561.85M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$553.00M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$539.96M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$526.50M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-06-30 | -$561.85M 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$553.00M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$539.96M 10-Q · filed 2024-08-19 |
| 2023-09-30 | -$526.50M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$510.82M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$495.79M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$477.95M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$451.02M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$425.00M 10-Q · filed 2022-08-02 |
| 2022-03-31 | -$397.99M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$364.94M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$336.29M 10-Q · filed 2021-11-16 |
| 2021-06-30 | -$297.87M 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$233.40M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$172.91M 10-K · filed 2022-03-15 |